Sign in
TELO Stock Price, Chart, Stats & News
Telomir Pharmaceuticals, Inc. Common Stock
Save
Telomir Pharmaceuticals, Inc. Common Stock (TELO) does not currently pay a dividend.
83.22M
Market cap
–
Current P/E
–
Forward P/E
TELO chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -141.84% |
ROE | -315.25% |
D/E | – |
Interest coverage ratio | -2588.13x |
TELO valuation
P/E | – |
P/S | – |
P/B | 7.27x |
P/CF | -11.65x |
P/FCF | -11.65x |
P/OCF | -11.65x |
PEG | -0.39x |
EV multiple | -4.79x |
About
Telomir Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical firm, concentrating its efforts on creating and launching novel therapeutic interventions. Its primary focus involves the development of TELOMIR-1, an innovative small molecule compound. This oral medication is being engineered to serve as a therapeutic solution against various age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, and also to assist in recovery post-chemotherapy.
Similar securities
Based on sector and market capitalization
Report issue